Insider Transactions in Q4 2025 at Gilead Sciences, Inc. (GILD)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.59%
|
$312,500
$125.23 P/Share
|
|
Nov 17
2025
|
Johanna Mercier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
28,000
-10.57%
|
$3,528,000
$126.05 P/Share
|
|
Nov 17
2025
|
Johanna Mercier Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+15.61%
|
$1,650,000
$66.64 P/Share
|
|
Nov 12
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Open market or private sale
|
Direct |
53,646
-24.84%
|
$6,598,458
$123.07 P/Share
|
|
Nov 12
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
53,646
+18.08%
|
$3,486,990
$65.54 P/Share
|
|
Oct 28
2025
|
Daniel Patrick O'Day Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$1,190,000
$119.18 P/Share
|
|
Oct 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
241
-0.55%
|
$28,920
$120.94 P/Share
|
|
Oct 25
2025
|
Deborah H Telman EVP, Corporate Affairs & GC |
BUY
Exercise of conversion of derivative security
|
Direct |
515
+1.16%
|
-
|
|
Oct 15
2025
|
Andrew D Dickinson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-1.57%
|
$295,000
$118.08 P/Share
|
|
Oct 15
2025
|
Johanna Mercier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,000
-2.65%
|
$354,000
$118.08 P/Share
|